• Skip to main content

Hearing Loss Treatment Report

www.HearingLossTreatmentReport.com

PACAP

Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss

March 22, 2021

CATEGORY:
Research

SCREENSHOT:
Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss

TITLE:
Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Plays a Protective Effect Against Noise-Induced Hearing Loss

CONTENT:
Front Cell Neurosci. 2021 Mar 22;15:658990. doi: 10.3389/fncel.2021.658990. eCollection 2021.

ABSTRACT

Pituitary adenylyl cyclase-activating polypeptide (PACAP) is a member of the vasoactive intestinal polypeptide (VIP)-the secretin-glucagon family of neuropeptides. They act through two classes of receptors: PACAP type 1 (PAC1) and type 2 (VPAC1 and VPAC2). Among their pleiotropic effects throughout the body, PACAP functions as neuromodulators and neuroprotectors, rescuing neurons from apoptosis, mostly through the PAC1 receptor. To explore the potential protective effect of endogenous PACAP against Noise-induced hearing loss (NIHL), we used a knockout mouse model lacking PAC1 receptor expression (PACR1-/- ) and a transgenic humanized mouse model expressing the human PAC1 receptor (TgHPAC1R). Based on complementary approaches combining electrophysiological, histochemical, and molecular biological evaluations, we show PAC1R expression in spiral ganglion neurons and in cochlear apical cells of the organ of Corti. Wild-type (WT), PAC1R-/- , and TgHPAC1R mice exhibit similar auditory thresholds. For most of the frequencies tested after acute noise damage, however, PAC1R-/- mice showed a larger elevation of the auditory threshold than did their WT counterparts. By contrast, in a transgene copy number-dependent fashion, TgHPAC1R mice showed smaller noise-induced elevations of auditory thresholds compared to their WT counterparts. Together, these findings suggest that PACAP could be a candidate for endogenous protection against noise-induced hearing loss.

PMID:33828461 | PMC:PMC8019930 | DOI:10.3389/fncel.2021.658990

SOURCE:
Frontiers in cellular neuroscience

PUBLISHER:

PMID:
pubmed:33828461

ID:
0b58ea4968e09ff10f4e1238c494f316pubmed:33828461

DOI:
10.3389/fncel.2021.658990

DATE – PUBLISHED:
Thu, 08 Apr 2021 06:00:00 -0400

DATE – DOI:
2021-03-22T06:42:56Z

DATE – ADDED:
04/08/21 01:18PM

LINK – PUBMED:
https://pubmed.ncbi.nlm.nih.gov/33828461/

LINK – DOI:
https://doi.org/10.3389/fncel.2021.658990

LINK – PUBLISHER:
https://www.frontiersin.org/articles/10.3389/fncel.2021.658990/full?utm_source=hearinglosstreatmentreport.com

IMAGE:

REFERENCE:
Hearing Loss Treatment Report, Urgent Research, 2021-04-08T17:18:29+00:00, https://www.hearinglosstreatmentreport.com.

Powered by Urgent Research

Copyright © 2025 Urgent Research